Cryo-EM structures of a serotonin gated ion channel
血清素门控离子通道的冷冻电镜结构
基本信息
- 批准号:9011376
- 负责人:
- 金额:$ 5.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAcidsAddressAdverse effectsAffinityAgonistAntiemeticsArchitectureBindingBinding SitesBiochemistryBiological Response Modifier TherapyBiophysicsCollaborationsComplexCryoelectron MicroscopyCrystallizationDrug usageEmeticsEnvironmentFamilyFamily memberGated Ion ChannelGoalsHealthHomoIn VitroIon ChannelLabelLaboratoriesLigandsLightLipidsMediatingMembraneMembrane ProteinsModelingMolecular ConformationNervous system structureNeurodegenerative DisordersNeurotransmittersNootropic AgentsPharmaceutical PreparationsPharmacologyPlayPropertyResolutionRoleSamplingSeriesSerotoninSerotonin Receptors 5-HT-3Signal TransductionStructureSynapsesSystemTRPV1 geneTrainingVariantWorkcancer therapychemotherapydesigngamma-Aminobutyric Acidhypnoticin vivoinsightmacromoleculemembernovelparticlereceptorreceptor functionreceptor structure functionreconstitutionresearch studyresponsesedativeserotonin 5 receptorserotonin receptor
项目摘要
DESCRIPTION (provided by applicant): Pentameric ligand-gated ion channels (pLGICs), i.e. cys-loop receptors, represent a major family of receptors in the nervous system that mediate rapid excitatory or inhibitory responses in synapses. Cys-loop receptors are targets of clinically important drugs such as sedative hypnotics, cognitive enhancers used in the treatment of neurodegenerative diseases, and anti-emetics used in cancer treatment. Despite their biological and therapeutic importance, atomic structures of many members of this family, including the serotonin receptor (5-HT3), are unknown and the structural mechanisms underlying pLGIC activation remain unresolved. My goal is to break this barrier by determining a series of atomic structures of the 5-HT3 receptor using single-particle cryo-electron microscopy (cryo-EM). My project will rely on the close collaboration between the labs of Yifan Cheng and David Julius here at UCSF, which recently led to the determination of a series of structures of the TRPV1 ion channel at near- atomic resolution (3-4 Å) using single particle cryo-EM. Having established a similar collaboration, David Julius' lab will provide training in membrane protein biophysics and biochemistry, enabling me to identify 5-HT3 variants with properties suitable for high resolution structural work. Making use of the Cheng lab's expertise in single particle cryo-EM, we will then determine high resolution structures of the 5-HT3 receptor in various functional states, including apo-, agonist- and antagonist-bound states, and resolve the binding sites and mechanisms of action of various 5-HT3 agonists and antagonists. Finally, experiments will be carried out to determine the arrangement of subunits within heteromeric 5-HT3, probe the consequences of lipid composition on 5-HT3 structure and function, and determine high resolution structures of these complexes. The experiments proposed in this project will show the structural transitions involved in channel gating, providing an atomic resolution model of 5-HT3 activation and also shedding light on the mechanism of Cys-loop receptors in general. Because activation of the 5-HT3 receptor causes many of the emetic side effects associated with chemotherapy, our studies will also provide a structural framework for the rational design of novel antiemetic drugs and chemotherapeutics with reduced side effects.
描述(由申请人提供):五聚体配体门控离子通道(pLGIC),即半胱氨酸环受体,代表神经系统中介导快速兴奋性或抑制性反应的主要受体家族,突触受体是半胱氨酸环受体的靶标。临床上重要的药物,例如镇静催眠药、用于治疗神经退行性疾病的认知增强剂以及用于癌症的止吐药尽管其生物学和治疗重要性,但该家族的许多成员(包括血清素受体(5-HT3))的原子结构尚不清楚,并且 pLGIC 激活的结构机制仍未解决。我的目标是通过确定 a 来打破这一障碍。使用单粒子冷冻电子显微镜(cryo-EM)研究 5-HT3 受体的一系列原子结构 我的项目将依赖于 Yifan Cheng 和 David Julius 实验室之间的密切合作。加州大学旧金山分校最近使用单粒子冷冻电镜以近原子分辨率 (3-4 Å) 确定了 TRPV1 离子通道的一系列结构。在建立了类似的合作之后,David Julius 的实验室将提供培训。在膜蛋白生物物理学和生物化学方面,我能够识别具有适合高分辨率结构工作的特性的 5-HT3 变体,然后利用 Cheng 实验室在单粒子冷冻电镜方面的专业知识,我们将确定 5-HT3 的高分辨率结构。研究不同功能状态下的5-HT3受体,包括apo结合状态、激动剂结合状态和拮抗剂结合状态,并解析各种5-HT3激动剂和拮抗剂的结合位点和作用机制,最后进行实验以确定其排列。异聚 5-HT3 内的亚基,探讨脂质组成对 5-HT3 结构和功能的影响,并确定这些复合物的高分辨率结构。该项目中提出的实验将显示通道门控中涉及的结构转变,从而提供。 5-HT3 激活的原子分辨率模型,也揭示了 Cys 环受体的一般机制,因为 5-HT3 受体的激活会导致许多与化疗相关的呕吐副作用,我们的研究还将提供一个结构。合理设计新型止吐药物和副作用减少的化疗药物的框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Bulkley其他文献
David Bulkley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Bulkley', 18)}}的其他基金
相似国自然基金
衣康酸碳点通过Nrf2-TFAM通路调控线粒体代谢治疗种植体周围炎的机制研究
- 批准号:82301131
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLA2G4B调控角质形成细胞脂肪酸代谢上调CCL20表达加重银屑病的机制研究
- 批准号:82304003
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向肠道SOAT2抑制胆固醇和脂肪酸摄取预防合并脂肪肝型胆固醇结石病形成的机制研究
- 批准号:82370649
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
水杨酸的生物合成及其调控抗病反应的机理研究
- 批准号:32330008
- 批准年份:2023
- 资助金额:218 万元
- 项目类别:重点项目
基于酸-碱共混策略制备兼具高固化效率与低熔点的耐高温芳腈基树脂的研究
- 批准号:22375134
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Peptibodies As Novel Therapies in Atrial Fibrillation
肽体作为心房颤动的新疗法
- 批准号:
10598711 - 财政年份:2023
- 资助金额:
$ 5.61万 - 项目类别:
Modulation of vestibular afferent properties by cholinergic and GABAergic inputs: from neural mechanisms to behavioral outcomes
胆碱能和 GABA 能输入对前庭传入特性的调节:从神经机制到行为结果
- 批准号:
10365156 - 财政年份:2022
- 资助金额:
$ 5.61万 - 项目类别:
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
针对睡眠、麻醉相关神经认知障碍和阿尔茨海默病的代谢干预
- 批准号:
10633125 - 财政年份:2022
- 资助金额:
$ 5.61万 - 项目类别:
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
针对睡眠、麻醉相关神经认知障碍和阿尔茨海默病的代谢干预
- 批准号:
10419578 - 财政年份:2022
- 资助金额:
$ 5.61万 - 项目类别:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
- 批准号:
10553649 - 财政年份:2021
- 资助金额:
$ 5.61万 - 项目类别: